Department of Psychiatry and Behavioral Health, Ohio State University Wexner Medical Center Talbot Hall, Columbus, OH, USA.
Bon Secours Mercy Health, Greenville, SC, USA.
Subst Use Misuse. 2024;59(2):312-315. doi: 10.1080/10826084.2023.2269571. Epub 2023 Dec 28.
Withdrawal is believed to play a central role in the brain disease model of addiction. However, little research describes withdrawal-motives among untreated individuals in community settings. This cross-sectional study surveyed syringe exchange program participants ( = 139) with untreated opioid use disorder (OUD) in Columbus, Ohio from January 10th to March 25th, 2023, to assess their perceptions of the role of withdrawal in OUD maintenance, treatment delay, and OUD's refractoriness to buprenorphine. Participants responded to a survey including DSM-5 OUD criteria, demographics, and questions about substance use and opioid withdrawal. Participant ages ranged from 21 to 65 years with a mean age of 37.5 years and standard deviation of 8.1. The racial distribution of the sample was as follows: 81% White/Caucasian, 12% Black/African American, 3% Native American or Alaskan Native. Sixty-six percent of participants agreed, or strongly agreed that opioid withdrawal was they had been unable to stop using opioids. Almost seventy-one percent agreed, or strongly agreed that worry about opioid withdrawal had caused them to OUD treatment. Although all participants had active, untreated OUD at the time of recruitment, most (85%) had previously tried buprenorphine, and the majority (78%) reported having experienced buprenorphine-precipitated withdrawal. Among this community sample of individuals with untreated OUD, withdrawal was perceived to have an important role in maintaining OUD, including by motivating OUD treatment delay. Prior buprenorphine-precipitated withdrawal was common, suggesting aversion to withdrawal might possibly be associated with OUD's refractoriness to buprenorphine.
戒断被认为在成瘾的大脑疾病模型中起着核心作用。然而,很少有研究描述未经治疗的个体在社区环境中戒断的动机。这项横断面研究调查了俄亥俄州哥伦布市未经治疗的阿片类药物使用障碍(OUD)的注射器交换计划参与者( = 139),时间为 2023 年 1 月 10 日至 3 月 25 日,以评估他们对 OUD 维持、治疗延迟和 OUD 对丁丙诺啡的难治性的看法。参与者回答了一项包括 DSM-5 OUD 标准、人口统计学、以及关于物质使用和阿片类药物戒断的问题的调查。参与者的年龄从 21 岁到 65 岁不等,平均年龄为 37.5 岁,标准差为 8.1。样本的种族分布如下:81%的参与者为白种人/高加索人,12%为黑种人/非裔美国人,3%为美国原住民或阿拉斯加原住民。66%的参与者同意或强烈同意,阿片类药物戒断是他们无法停止使用阿片类药物的原因。几乎 71%的参与者同意或强烈同意,对阿片类药物戒断的担忧导致他们延迟接受 OUD 治疗。尽管所有参与者在招募时都患有未经治疗的活跃 OUD,但大多数(85%)曾尝试过丁丙诺啡,大多数(78%)报告曾经历过丁丙诺啡引发的戒断。在这个未经治疗的 OUD 社区样本中,戒断被认为在维持 OUD 方面起着重要作用,包括通过激励 OUD 治疗延迟。先前的丁丙诺啡引发的戒断很常见,这表明对戒断的厌恶可能与丁丙诺啡对 OUD 的难治性有关。